Scientific Presentations

2011

June 2011 - Analysis of minority-based community clinical oncology (MBCCOP) accrual activity. The 2011 Annual meeting of the American Society of Clinical Oncology, Chicago, IL.

2008

June 2008 - Phase II trial of concurrent full dose radiation, cisplatin and cetuximab in unresectable, locally advanced squamous cell carcinoma of the head and neck [LA-SSCHN]: Results of Eastern Cooperative Oncology Group (ECOG) Trial 3303. The 2008 Annual meeting of the American Society of Clinical Oncology, Chicago, IL.

2007

September 2007 - Poverty predicts aggressive breast cancer phenotype and poor prognosis. ASCO - The Breast Cancer Symposium: Integrating Emerging Science into Clinical Practice, San Francisco, CA.

June 2007 - Absence of racial predilection for aggressive tumor phenotype among low social-economic status women with breast cancer. The 2007 Annual meeting of the American Society of Clinical Oncology, Chicago, IL.

April 2007 - Basal subtype predicts poorer prognosis in younger, but not older, African-American women with breast cancer. The 98th annual meeting of the American Association for Cancer Research, Los Angeles, CA.

2006

December 2006 - p53 gene mutations in African-American women with breast cancer. The 29th Annual San Antonio Breast Cancer Symposium, San Antonio, TX (Submitted).

September 2006 - p53 status is more likely than basal subtype to predict survival in African-American women with breast cancer. AACR Molecular Diagnostics in Cancer Therapeutic Development: Maximizing Opportunities for Individualized Treatment, Chicago, IL.

June 2006 - p53 expression in breast cancer is more likely to predict survival in African-American than Hispanic or white women. The 2006 Annual meeting of the American Society of Clinical Oncology, Atlanta, GA.

April 2006 - Underserved African-American & white women with breast cancer have similar prognostic profiles for estrogen receptor and tumor grade. The 97th annual meeting of the American Association for Cancer Research, Washington, DC.

2005

December 2005 - Low socio-economic status African-American, Hispanic White women with breast cancer demonstrate similar hormone receptor status, tumor grade survival. The 28th Annual San Antonio Breast Cancer Symposium, San Antonio, TX.

April 2005 - HER2/neu overexpression and survival in African-American women with breast cancer. The 96th annual meeting of the American Association for Cancer Research, Anaheim, CA.

April 2005 - Health attitudes, beliefs and habits affect breast cancer screening practice among minority-underserved and low income women. The 96th annual meeting of the American Association for Cancer Research, Anaheim, CA.

2004

December 2004 - Improved yield of perioperative screening for metastases in African-American women with operable breast cancer. The 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX.

December 2004 - Analysis of hormone receptor function in African-American women with breast cancer. The 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX.

May 2004 - Delivering the Continuum of Breast Cancer Care to the Underserved: Treatment Issues. 2nd annual Avon Symposium at UCSF Comprehensive Cancer Center, San Francisco, CA.

March 2004 - HER2/neu Status in African-American Women with Breast Cancer. The 95th annual meeting of the American Association for Cancer Research, Orlando, FL.

March 2004 - Early Stage Interval Breast Cancers in African-American Women Demonstrate ER Negative Status & More Aggressive Tumor Biology. The 95th annual meeting of the American Association for Cancer Research, Orlando, FL.

March 2004 - Poor Quality Reporting of Screening Mammography is Associated with Lower Rates of Diagnosis of Early-Stage Breast Cancer in Minority-Underserved Women. The 95th annual meeting of the American Association for Cancer Research, Orlando, FL.

2003

December 2003 - Technical differences contribute to hormone receptor negative status in African-American underserved patients. The 26th Annual San Antonio Breast Cancer Symposium, San Antonio, TX.

December 2003 - ER beta expression parallels ER alpha/ PR expression and is inversely related to EGFR expression in African American women with breast cancer. The 26th Annual San Antonio Breast Cancer Symposium, San Antonio, TX.

November 2003 - The Significance of p53 Immunoreactivity in African-American Patients with Breast Cancer. The Association for Cancer Surgery at the Royal College of Surgeons of England , London , U.K.

October 2003 - Outcome Disparity for Preoperative or Neoadjuvant Chemotherapy in African-American Breast Cancer Patients. AACR Special Conference, Advances in Breast Cancer Research: Genetics, Biology & Clinical Applications, Huntington Beach, CA.

October 2003 - p53 Immunostaining in African-American Breast Cancer Patients is Significantly Associated with Higher Stage & Negative Hormone Receptor Status. AACR Special Conference, Advances in Breast Cancer Research: Genetics, Biology & Clinical Applications, Huntington Beach, CA.

July 2003 - Minority-Underserved Women Treated for Breast Cancer Are at Increased Risk for Poor Mental Health Outcomes. The 94th annual meeting of the American Association for Cancer Research, Washington, DC.

July 2003 - Evaluation of p53 Immunoreactivity in African-American Patients with Breast Cancer. The 94th annual meeting of the American Association for Cancer Research, Washington, DC.

July 2003 - Lower Rates of Diagnosis of Early-Stage Breast Cancer in Minority-Underserved Patients is Associated with Inadequate Screening Practice. The 94th annual meeting of the American Association for Cancer Research, Washington, DC.

May 2003 - Recruitment & Retention of Minority-Underserved Participants to the Star/P2 study is Difficult. The 2003 Annual meeting of the American Society of Clinical Oncology, Chicago, IL.

2002

December 2002 - Fine needle aspirate biopsies of breast lesions are more commonly unsatisfactory and inaccurate when performed by non-surgeons. The 25th Annual San Antonio Breast Cancer Symposium, San Antonio, TX.

October 2002 - Analysis of results for breast cancer screening & early detection in minority-underserved American women. The Fourth Annual Lynn Sage Breast Cancer Symposium, Northwestern University, Chicago, IL.

July 2002 - Black women with breast cancer are more likely to be ER-beta positive. British Cancer Research Meeting 2002, Glasgow, Scotland.

July 2002 - Her2/Neu overexpression in Black women with breast cancer is not associated with negative ER status or higher stage disease. British Cancer Research Meeting 2002, Glasgow, Scotland.

April 2002 - Comparison of prognostic factors for minority-underserved patients with breast cancer. The 93rd annual meeting of the American Association for Cancer Research, San Francisco, CA.

April 2002 - Outcomes for breast cancer screening & early detection in minority-underserved women. The 93rd annual meeting of the American Association for Cancer Research, San Francisco, CA.

April 2002 - Analysis of results for breast cancer screening & early detection in minority-underserved American women. The 11th Congress of the European Society of Surgical Oncology, Lille, France.

April 2002 - A comparison of prognostic factors for minority-underserved American patients with breast cancer. The 11th Congress of the European Society of Surgical Oncology, Lille, France.

April 2002 - A Surgical Perspective of Breast Cancer Screening & Early-Detection in Minority-Underserved Women. Chicago Board of Health, Grand Rounds, Chicago, IL.

February 2002 - Factors influencing post-mastectomy breast reconstruction among minority-underserved patients. The 7th Annual Multidisciplinary Symposium on Breast Disease, Amelia Island, FL.

2001

May 2001 - Clinical trials and tribulations at CCH: implementation of NSABP breast cancer studies. Spring Meeting of the Illinois Surgical Society at CCH, Chicago, IL.

March 2001 - Prognostic Differences for African-American and Other Medically-Underserved Patients with Breast Cancer. The 92nd annual meeting of the American Association for Cancer Research, New Orleans, LA.